A chewable multivitamin has been recalled across 25 states after inspections by the U.S. Food and Drug Administration (FDA) revealed it contained lower-than-intended levels of vitamin D. The affected product, known as Multivitamin with Fluoride Chewable Tablets, grape flavor, was manufactured by Winder Laboratories, LLC, based in Winder, Georgia.
The recall, initiated on October 27, 2025, affects two specific versions of the multivitamin. The first contains 0.25 mg of fluoride in bottles of 100 tablets with National Drug Code (NDC) 75826-169-10 and UPC 3 15826 16910 2. The second version features 1.0 mg of fluoride in similar packaging, identified by NDC 75826-171-10 and UPC 3 15826 17110 5.
The FDA’s inspection indicated that the multivitamin was subpotent in vitamin D, meaning it contained less of this essential nutrient than intended. Vitamin D is crucial for bone health, as it aids the body in absorbing calcium, and it also plays a significant role in supporting the immune system.
Details of the Recall
The voluntary recall encompasses 422 cases of the 0.25 mg product and 210 cases of the 1.0 mg product, with each case containing 12 bottles of 100 tablets. Consumers can identify the impacted products by their lot numbers and expiration dates:
– Lot 1692303, serial number 138909557498, expiration date October 26, 2025
– Lot 1692304, serial number 131163901709, expiration date October 26, 2025
– Lot 1712301, serial number 163590222021, expiration date November 14, 2025
This recall is cataloged under recall number H-0569-2026 and is associated with FDA Event ID 97884. Initial notifications were sent to consumers via letter.
Distribution records reveal that the affected products were shipped to various states, including Alabama, California, Florida, Texas, and others, as well as Puerto Rico.
FDA Risk Classification
The FDA has classified this recall as Class III, the lowest risk category. This classification indicates that while the product does not pose a significant health risk, it still violates FDA regulations. The subpotency of vitamin D, although not likely to cause adverse health effects, necessitates corrective action from the manufacturer.
As of now, the recall remains ongoing with no termination date specified. Consumers are advised to check their supplies and follow the guidance provided by the FDA and the manufacturer regarding the recall.
